Endonovo Therapeutics, Inc. (ENDV): Net Income
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$18.47M
Year ended 2022-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | -$18.47M | n/m | 2023-04-17, From 2022-01-01 |
| 2021-12-31 | -$3.10M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | -$395.6K | n/m | 2022-04-14, From 2020-01-01 |
| 2019-12-31 | -$17.31M | n/m | 2021-04-13, From 2019-01-01 |
| 2018-12-31 | -$6.44M | n/m | 2020-05-04, From 2018-01-01 |
| 2017-12-31 | -$10.81M | n/m | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | -$5.32M | n/m | 2018-04-06, From 2016-01-01 |
| 2015-12-31 | -$6.77M | n/m | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | -$959.5K | n/m | 2016-05-17, From 2014-01-01 |
| 2013-12-31 | -$2.89M | n/m | 2015-06-15, From 2013-01-01 |
| 2012-12-31 | -$1.91M | n/m | 2013-05-03, From 2012-01-01 |
| 2011-12-31 | -$94.1K | n/m | 2012-04-13, From 2011-01-01 |
| 2010-12-31 | -$69.4K | n/a | 2012-04-13, From 2010-01-01 |